Altered behavior in mice overexpressing soluble ST2.
Animals
Anxiety
/ genetics
Behavior Rating Scale
Behavior, Animal
/ physiology
Depression
/ genetics
Disease Models, Animal
Interleukin-1 Receptor-Like 1 Protein
/ genetics
Learning
/ physiology
Maze Learning
/ physiology
Memory
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Transgenic
Motor Activity
/ genetics
Social Behavior
Swimming
Up-Regulation
Depression
Forced swimming test
Mouse
Soluble ST2
Tail suspension test
Journal
Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876
Informations de publication
Date de publication:
11 05 2020
11 05 2020
Historique:
received:
05
08
2019
accepted:
22
04
2020
entrez:
13
5
2020
pubmed:
13
5
2020
medline:
4
6
2021
Statut:
epublish
Résumé
Psychoneuroimmunological studies have clearly demonstrated that both cellular and humoral immunity are related to major depression. Soluble ST2 is regarded as a key molecule regulating immune system as well as cell proliferation. Indeed, soluble ST2 is reported to reduce IL-33-induced IL-6 and TNF-α production in macrophages and IL-33-induced IL-5 and IL-13 production in type 2 innate lymphoid cells. Elevated serum concentrations of soluble ST2 have been reported in patients with neuropsychiatric disorders, suggesting pathophysiological roles of soluble ST2 in behavioral phenotypes. Nevertheless, the relation between soluble ST2 and depressive behavior remain to be uncovered. To complement this point, we performed broad behavioral phenotyping, utilizing transgenic mice with a high concentration of serum ST2 in the present study. Soluble ST2 overexpression mice (ST2 Tg mice) were generated on a C3H/HeJ background. ST2 Tg mice crossed onto the BALB/c genetic background were used. Before starting tests, each mouse was observed in a clean cage for a general health check and neurological screening tests. In Experiment I, comprehensive behavioral phenotyping was performed to reveal the role of soluble ST2 on sensorimotor functions, anxiety-like behaviors, depression-like behaviors, social behaviors, and learning and memory functions. In Experiment II, to confirm the role of soluble ST2 on depression-like behaviors, a depression test battery (two bottle choice test, forced swimming test, and tail suspension test) was applied. The general health check indicated good general health and normal gross appearance for ST2 Tg mice. Further, the neurological reflexes of all the mice were normal. We found that soluble ST2 overexpression resulted in decreased social interaction. Moreover, depression-like behaviors of ST2 Tg mice were observed in two well-established behavioral paradigms, the forced swimming test and the tail suspension test. Nevertheless, hedonic reaction to sucrose was observed in ST2 Tg mice similar to WT mice. These results suggest the depression in the ST2 Tg mice. In conclusion, through a series of experiments, we established the animal model for assessing role of soluble ST2 in neuropsychiatric disorders, and revealed the possible involvement of soluble ST2 in depressive behavior.
Identifiants
pubmed: 32393354
doi: 10.1186/s13041-020-00606-4
pii: 10.1186/s13041-020-00606-4
pmc: PMC7216579
doi:
Substances chimiques
Il1rl1 protein, mouse
0
Interleukin-1 Receptor-Like 1 Protein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Références
PLoS One. 2015 Mar 25;10(3):e0122118
pubmed: 25806517
Am J Respir Crit Care Med. 2001 Jul 15;164(2):277-81
pubmed: 11463601
J Immunol. 2008 Oct 1;181(7):4780-90
pubmed: 18802081
Mol Psychiatry. 2013 Jun;18(6):666-73
pubmed: 22688187
FEBS Lett. 1993 Feb 22;318(1):83-7
pubmed: 7916701
Cell Signal. 2008 Sep;20(9):1679-86
pubmed: 18603409
Nature. 1977 Apr 21;266(5604):730-2
pubmed: 559941
Front Immunol. 2018 Nov 20;9:2596
pubmed: 30515150
Curr Immunol Rev. 2010 Aug;6(3):205-212
pubmed: 21170282
Eur J Immunol. 2010 Sep;40(9):2632-42
pubmed: 20662097
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Chest. 2003 Oct;124(4):1206-14
pubmed: 14555548
eNeuro. 2017 Dec 26;4(6):
pubmed: 29379874
Circulation. 2003 Feb 11;107(5):721-6
pubmed: 12578875
Biochem Biophys Res Commun. 2001 Jun 29;284(5):1104-8
pubmed: 11414697
J Biol Chem. 2007 Sep 7;282(36):26369-80
pubmed: 17623648
Biol Psychiatry. 2009 Feb 15;65(4):296-303
pubmed: 18801471
Compr Psychiatry. 2017 Apr;74:96-101
pubmed: 28126482
Nature. 1961 Jul 29;191:474-6
pubmed: 13762409
Psychopharmacology (Berl). 1988;94(2):147-60
pubmed: 3127840
Brain Behav Immun. 2007 Aug;21(6):727-35
pubmed: 17604598
Genes Brain Behav. 2002 Jan;1(1):55-69
pubmed: 12886950
Genes Brain Behav. 2004 Aug;3(4):228-39
pubmed: 15248868
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2705-13
pubmed: 27091974
EMBO J. 1994 Mar 1;13(5):1176-88
pubmed: 8131748
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
FEBS Lett. 1989 Dec 4;258(2):301-4
pubmed: 2532153
Obesity (Silver Spring). 2016 Apr;24(4):886-94
pubmed: 26890672
PLoS Biol. 2009 Feb 24;7(2):e41
pubmed: 19243221
Neuroscience. 2003;117(1):221-7
pubmed: 12605908
Circulation. 2002 Dec 3;106(23):2961-6
pubmed: 12460879
Neurogastroenterol Motil. 2011 Mar;23(3):255-64, e119
pubmed: 21054680
Clin Exp Allergy. 2002 Oct;32(10):1520-6
pubmed: 12372135
Mol Psychiatry. 2004 Apr;9(4):326-57
pubmed: 14743184
J Clin Invest. 2016 Dec 1;126(12):4469-4481
pubmed: 27775548
Biochem Biophys Rep. 2016 Feb 03;5:401-407
pubmed: 28955848
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3047-52
pubmed: 21282636
J Neurovirol. 2004 Oct;10(5):284-92
pubmed: 15385251